Justicia procumbens suppresses high-fat diet-induced weight gain in mice and adipogenesis in 3T3-L1 cells with inhibition of AKT and STAT3 phosphorylation
4 affiliations
- 1Department of Advanced BioConvergence, School of Food Science and Biotechnology, Kyungpook National University
- 2College of Pharmacy, Yonsei Institute of Pharmaceutical Science, Yonsei University
- 3Department of Biotechnology, Yonsei University
- 4Biological Resources Research Division, National Institute of Biological Resources
Abstract
Obesity is a major public health concern, and the long-term use of current pharmacological therapies can be constrained by adverse effects. Therefore, natural products with potential applicability to obesity management are of growing interest. Here, we investigated the anti-obesity effects of an extract of Justicia procumbens (JE), a traditionally used medicinal plant, and its underlying mechanisms. Oral administration of JE in a high-fat diet-induced obese mouse model significantly reduced body weight gain, white adipose tissue mass, hepatic lipid accumulation, and circulating triglyceride levels. Chemical profiling of JE followed by chromatographic purification and structural characterization identified seven lignans and lignan glycosides, including two previously undescribed lignan glycosides. Network pharmacology analysis highlighted phosphorylation-related signaling pathways associated with adipogenesis, particularly PI3K-AKT and JAK-STAT signaling, as candidate mechanisms of JE action. Consistent with these predictions, JE suppressed adipogenic differentiation and attenuated AKT-p70S6K and STAT3 phosphorylation in 3T3-L1 preadipocytes and white adipose tissue. Functional screening further identified four lignan compounds with anti-adipogenic activity that differentially attenuated AKT or STAT3 phosphorylation. Collectively, our findings demonstrate that JE suppresses adipogenesis and attenuates obesity-associated metabolic abnormalities, highlighting its potential as a plant-derived candidate for obesity management.
Related
- Inhibition of DCLK1 promotes spinal cord injury recovery: implications for KATNA1 phosphorylation in microtubule-dependent neurite outgrowth
- A Marine Bivalve (Entodesma navicula) Extract Suppresses the Replication of Influenza Viruses and Flaviviruses in Association with Reduced MLKL Phosphorylation.
- Apigenin suppresses ovarian cancer cell growth by disrupting TGF-beta1-mediated cancer–stroma interaction via AKT inhibition
- Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway [Retraction].
- Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling
BibTeX
@article{kim2026justicia,
title = {{Justicia procumbens suppresses high-fat diet-induced weight gain in mice and adipogenesis in 3T3-L1 cells with inhibition of AKT and STAT3 phosphorylation}},
author = {Yeeun Kim and Seoyeon Lee and Jun Hyung Park and Chaewon Lee and Gaeun Kwon and Meiling Xian and Minju Jeong and Youn Kyoung Son and Sarah Lee and Ga Ryun Kim and Sanguine Byun and Seung Hyun Kim and Joe Eun Son},
journal = {Frontiers in Pharmacology},
year = {2026},
month = nov,
doi = {10.3389/fphar.2026.1959162},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1959162/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Justicia procumbens suppresses high-fat diet-induced weight gain in mice and adipogenesis in 3T3-L1 cells with inhibition of AKT and STAT3 phosphorylation
AU - Yeeun Kim
AU - Seoyeon Lee
AU - Jun Hyung Park
AU - Chaewon Lee
AU - Gaeun Kwon
AU - Meiling Xian
AU - Minju Jeong
AU - Youn Kyoung Son
AU - Sarah Lee
AU - Ga Ryun Kim
AU - Sanguine Byun
AU - Seung Hyun Kim
AU - Joe Eun Son
PY - 2026
DA - 2026/11/04
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1959162
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1959162/full
AB - Obesity is a major public health concern, and the long-term use of current pharmacological therapies can be constrained by adverse effects. Therefore, natural products with potential applicability to obesity management are of growing interest. Here, we investigated the anti-obesity effects of an extract of Justicia procumbens (JE), a traditionally used medicinal plant, and its underlying mechanisms. Oral administration of JE in a high-fat diet-induced obese mouse model significantly reduced body weight gain, white adipose tissue mass, hepatic lipid accumulation, and circulating triglyceride levels. Chemical profiling of JE followed by chromatographic purification and structural characterization identified seven lignans and lignan glycosides, including two previously undescribed lignan glycosides. Network pharmacology analysis highlighted phosphorylation-related signaling pathways associated with adipogenesis, particularly PI3K-AKT and JAK-STAT signaling, as candidate mechanisms of JE action. Consistent with these predictions, JE suppressed adipogenic differentiation and attenuated AKT-p70S6K and STAT3 phosphorylation in 3T3-L1 preadipocytes and white adipose tissue. Functional screening further identified four lignan compounds with anti-adipogenic activity that differentially attenuated AKT or STAT3 phosphorylation. Collectively, our findings demonstrate that JE suppresses adipogenesis and attenuates obesity-associated metabolic abnormalities, highlighting its potential as a plant-derived candidate for obesity management.
SN - 1663-9812
ER -